What is AnGes Inc?
engages in the research and development of gene-based medicines.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
engages in the research and development of gene-based medicines. It develops HGF gene therapy product for the treatment of chronic arterial occlusive disease; NF-KB decoy oligonucleotide for chronic discogenic lumbar back pain; and DNA vaccines for the treatment of hypertension, as well as tie2 agonists for COVID-19/ARDS and drugs for chronic hepatitis B. The company is listed on the OTCGREY in USA, operating in the Healthcare sector, with a market capitalisation of 142.50M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.